These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 11358938

  • 21. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, Takeshita A.
    Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
    [Abstract] [Full Text] [Related]

  • 22. Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics.
    Ono H, Ono Y, Frohlich ED.
    Hypertension; 1995 Aug; 26(2):249-55. PubMed ID: 7543452
    [Abstract] [Full Text] [Related]

  • 23. Mibefradil prevents L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Qiu C, Bruneval P, Roeckel A, Heudes D, Duong Van Huyen JP, Roux S.
    J Hypertens; 1999 Oct; 17(10):1489-95. PubMed ID: 10526911
    [Abstract] [Full Text] [Related]

  • 24. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

  • 25. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
    Takahashi T, Ono H, Ono Y, Ishimitsu T, Matsuoka H.
    Int Heart J; 2007 Sep; 48(5):637-47. PubMed ID: 17998773
    [Abstract] [Full Text] [Related]

  • 26. Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid.
    Ito O, Omata K, Ito S, Hoagland KM, Roman RJ.
    Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R822-30. PubMed ID: 11171663
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
    Wada T, Inada Y, Ojima M, Sanada T, Shibouta Y, Nishikawa K.
    Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
    [Abstract] [Full Text] [Related]

  • 28. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA, Paffaro VA, Pauli JR, da Silva GH, Saad MJ, Salgado I, da Cruz-Höfling MA, Hyslop S.
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [Abstract] [Full Text] [Related]

  • 29. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S, Nishikimi T, Inaba C, Akimoto K, Matsuoka H.
    J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
    [Abstract] [Full Text] [Related]

  • 30. Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition.
    Biwer LA, D'souza KM, Abidali A, Tu D, Siniard AL, DeBoth M, Huentelman M, Hale TM.
    Hypertens Res; 2016 Jan; 39(1):8-18. PubMed ID: 26490086
    [Abstract] [Full Text] [Related]

  • 31. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D, Porteri E, Bettoni G, Piccoli A, Castellano M, Muiesan ML, Pasini G, Guelfi D, Rosei EA.
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
    Watanabe S, Ono H, Ishimitsu T, Matsuoka H, Ono Y, Fujimori T.
    Hypertens Res; 2000 Nov; 23(6):683-91. PubMed ID: 11131282
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
    Kim S, Zhan Y, Izumi Y, Iwao H.
    Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
    [Abstract] [Full Text] [Related]

  • 39. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
    [Abstract] [Full Text] [Related]

  • 40. Angiotensin-converting enzyme inhibition in adult hypertensive rats: a stereological study of renal filtration surface area.
    Dunstan HJ, Briscoe TA, Bertram JF, Johnston CI, Black MJ.
    Clin Exp Pharmacol Physiol; 2003 Aug; 30(1-2):72-6. PubMed ID: 12542457
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.